Compounded Semaglutide
US$ 20.06
retatrutide trails FDA Approval Status 2026: Everything We Know So Far Looking forward to when #retatrutide's
Description
Both tirzepatide and retatrutide are made by Eli Lilly, and the transition would involve a standard dose titration protocol
doi: 10.1136/jnnp.2007.137026
Retatrutide has not received marketing authorisation from the MHRA, EMA, or FDA and cannot be legally prescribed outside authorised clinical trials
With continued use, reports of GI issues tend to taper off
79% of cases identified eventually resolved
Like other GLP-1 drugs, it carries a boxed warning for possible thyroid tumors and other risks such as pancreatitis or gallbladder problems, so its important to use it under a doctors guidance
